Application:

1. Type 2 Diabetes Management: Trelagliptin succinate is primarily used for the management of type 2 diabetes mellitus. It belongs to a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. Trelagliptin works by inhibiting the DPP-4 enzyme, which increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This leads to improved glucose control by increasing insulin secretion and decreasing glucagon release, ultimately helping to regulate blood sugar levels.

2. Glycemic Control: Trelagliptin succinate is prescribed to help maintain glycemic control in patients with type 2 diabetes. By enhancing the body's own mechanisms for glucose regulation, it can contribute to reducing elevated blood sugar levels and improving overall glycemic control.

3. Adjunct to Diet and Exercise: Trelagliptin succinate is typically prescribed as an adjunct therapy to diet and exercise for the management of type 2 diabetes. It is often used in combination with other antidiabetic medications, such as metformin, sulfonylureas, or insulin, to provide comprehensive glycemic control.

4. Long-Lasting Effect: Trelagliptin succinate is known for its prolonged duration of action. It has a relatively long half-life, allowing for once-weekly dosing, which may improve treatment adherence and convenience for patients.

5. Elderly Patients: Trelagliptin succinate is commonly used in elderly patients with type 2 diabetes due to its favorable pharmacokinetic profile and once-weekly dosing regimen. It can be particularly beneficial for older individuals who may have difficulty adhering to complex medication regimens.

If you need similar products, please contact my email : admin04@hsnm.com.cn